Clinical Trial Update: Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

This Phase 4 trial in older adults with acute coronary syndrome is evaluating whether intravenous iron improves quality of life and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Iron Deficiency

Drugs mentioned

• Intravenous iron

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Acute Coronary Syndromes (ACS), Iron Deficiencies | Phase 4 | Status: RECRUITING